News & Perspective

Sep 17, 2002

Sep 17, 2002

Atopic dermatitis could rule out smallpox shots for large share of population

(CIDRAP News) – The current high prevalence of eczema, or atopic dermatitis (AD), suggests that a large share of the population could be at risk for the serious side effect of eczema vaccinatum (EV) if they underwent smallpox vaccination, according to specialists writing in the September Journal of Allergy and Clinical Immunology.

Sep 16, 2002

Sep 16, 2002

FDA issues draft guidance on controlling pathogens in juices

(CIDRAP News) – The Food and Drug Administration (FDA) is inviting public comments on a new draft report on how to control microbial pathogens in juices.

Sep 13, 2002

Sep 13, 2002

FDA planning new adverse-event reporting system for food, supplements

(CIDRAP News) – The Food and Drug Administration (FDA) says it is taking several steps to improve the monitoring and analysis of adverse events related to food products, dietary supplements, and cosmetics.

The FDA's Center for Food Safety and Applied Nutrition (CFSAN) announced it is working on a single adverse event reporting system that will replace separate systems for the three categories of products.

Sep 12, 2002

Sep 12, 2002

Study suggests how anthrax sabotages innate immune system

(CIDRAP News) – Researchers report they have discovered the probable strategy that anthrax uses to kill macrophages, a step that may allow the pathogen to escape detection by the innate immune system.

Sep 11, 2002

Sep 11, 2002

MMWR will post terrorism-related reports ahead of schedule

(CIDRAP News) – Morbidity and Mortality Weekly Report will publish electronic reports related to terrorism and other public health emergencies whenever necessary instead of waiting for the usual weekly publication day, the Centers for Disease Control and Prevention (CDC) announced yesterday.

Sep 11, 2002

Sep 11, 2002

IOM says military vaccine program needs revamping, more money

(CIDRAP News) – The Department of Defense's (DoD's) vaccine acquisition program is poorly organized and underfunded, making it difficult for the department to obtain important vaccines and maintain the supply of existing ones, according to a new report from the Institute of Medicine (IOM).

Sep 10, 2002

Sep 10, 2002

Value of 'syndromic surveillance' for bioterrorism unclear from post-Sep 11 experience

(CIDRAP News) – After the Sep 11 attacks in New York City, health officials quickly launched a program of syndromic surveillance—the classification and counting of emergency department cases according to whether or not they initially looked like a disease potentially caused by bioterrorism. The goal was to provide an early warning of any biological attack.

Sep 09, 2002

Sep 09, 2002

Anthrax decontamination workers should get vaccine or antibiotics, CDC says

(CIDRAP News) – Workers who decontaminate buildings tainted with anthrax (Bacillus anthracis) spores should be vaccinated against the disease or receive preventive antibiotic treatment, according to new guidelines from the Centers for Disease Control and Prevention (CDC).

Sep 06, 2002

Sep 06, 2002

Effect of antibiotics on HUS risk in E coli patients called unclear

(CIDRAP News) – A recent meta-analysis does not support the idea that antibiotic treatment increases the risk of hemolytic uremic syndrome (HUS) in patients with Escherichia coli O157:H7 enteritis, but the authors say the question isn't settled yet.

Sep 05, 2002

Sep 05, 2002

Acambis reports successful phase I trial of cell-culture-grown smallpox vaccine

(CIDRAP News) Ð The smallpox vaccine being produced by Acambis plc for the US government as part of the nation's bioterrorism preparedness program worked well in a Phase I trial, Acambis officials announced this week.

The vaccine, called ACAM1000, generated a characteristic skin lesion or "take" in all those vaccinated, and there were no serious or unusual side effects, the company reported in a Sep 3 news release.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»